Research Directory

Novimmune's antibody strategy attracks investors

Read more

An interview with Seventure Partners: Is grass greener on the other side of the Manche?

Read more

EMEA explains new certification scheme

Read more

Novacta targets C. difficile the natural way

Read more

Novacta targets C. difficile the natural way

Read more

How IP Group helps universities commercialise research

Read more

How China's new patent law will affect life science companies

Read more

The Obama impact on stem cell research

Read more

MIT's Technology Licensing Office

Read more

Aravis Venture looks to get a step ahead by finding the right targets

Read more